Imatinib vs Methotrexate
Imatinib vs Methotrexate: Overview
This comparison examines the pharmacological differences between Imatinib and Methotrexate.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Imatinib β 18 hours; Methotrexate β 3-10 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O; Methotrexate β C20H22N8O5.
Molecular Weight: Imatinib β 493.6030 g/mol; Methotrexate β 454.4400 g/mol.
Type: Imatinib β Small molecule; Methotrexate β Small molecule.